Vision rehab study for veterans with age-related macular degeneration
Part of Eyes & vision clinical trials.
This trial studies a vision rehabilitation approach for veterans who have vision loss from age-related macular degeneration. The goal is to see whether the training improves how well people can use vision despite their eye condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a Veteran and be at least 50 years old
- You have age-related macular degeneration diagnosed by an eye doctor
- Your vision is reduced to 20/40 or worse in each eye, even with glasses/contacts
- Tests show your vision has specific field gaps or missing/dark areas, and this is confirmed by clinic eye tests
- You have not started any other rehabilitation treatment for AMD vision loss yet
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an active (aerobic) exercise program can improve day-to-day function in Veterans with intermediate age-related macular degeneration (AMD). To join, you must have the right type stage of AMD, be able to do the assessments and exercise, and meet health and internet needs.
This trial tests whether visual rehabilitation can help improve both vision and mood in people with advanced dry age-related macular degeneration. It aims to understand the link between vision loss and depression.
This trial tests a new approach to improve vision in people with end-stage age-related macular degeneration (AMD). It aims to help those whose vision has dropped to a moderate or severe level, even with glasses, and who are not contact lens wearers.
This study uses virtual reality tests to see if they can measure vision changes in people with age-related macular degeneration (AMD), a condition that affects central vision. It compares results from healthy volunteers and people at different stages of AMD.
This study tests a device that is surgically implanted in the eye of people with late-stage age-related macular degeneration (AMD). It also uses vision training with a telescope-like tool to see if the treatment can improve day-to-day vision.
This trial studies a vision treatment approach for people age 50+ who have dry age-related macular degeneration (AMD) and are legally blind from it. It aims to see whether the treatment can improve vision-related outcomes in the study eye.
Hear when a new Age-related Macular Degeneration (AMD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.